Thyroid Eye Disease: Practical Approaches and Solutions That Improve Management
This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Activity Description
Thyroid eye disease (TED) is often misdiagnosed due to its heterogeneous presentation, while ophthalmologists continue to face challenges in their diagnoses and management of these patients. Early diagnosis and treatment of the disease are most effective during the initial active phase and are essential to reduce vision loss. Managing patients with TED include normalizing thyroid levels; using magnetic resonance imaging and computed tomography to aid in differential diagnosis; and applying medical therapies such as steroids, biologics, and radiotherapy to reduce symptoms as well as increase the quality of life. Alongside traditional therapies, a novel mechanism targeting insulin-like growth factor-1 and thyroid-stimulating hormone receptors has been proven to reduce disease activity and proptosis. In addition to medical therapies, multidisciplinary cooperation is essential for the proper support and treatment of patients with TED. In this CE activity, expert faculty will evaluate tools for differential diagnosis; assess real-world evidence for the safety and efficacy of available therapies; and present multidisciplinary approaches to improve the management of TED.
Target Audience
The intended audience for this activity includes comprehensive ophthalmologists and other healthcare professionals involved in the management of patients with TED.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Examine practices and procedures that aid in the differential diagnosis of TED.
- Summarize multidisciplinary approaches that improve the management of TED.
- Evaluate real-world clinical evidence regarding the safety and efficacy of therapies used in the treatment of TED.
Activity Chair
Andrea Lora Kossler, MD, FACS
Director, Oculofacial Plastic and Orbital Surgery
Associate Professor of Ophthalmology
Byers Eye Institute at Stanford University School of Medicine
Palo Alto, CA
Faculty
Jennifer M. Loh, MD
Medical Director, Loh Ophthalmology Associates
Board Member, Eye Physicians of Florida
Clinical Faculty, Larkin Hospital Ophthalmology Residency
Miami, FL
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, November 30, 2023, to November 29, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Andrea Lora Kossler, MD, FACS
Consultant: Acelyrin, Argenx, Horizon, Immunovant, Viridian
Independent Research Contractor: Horizon, Sling, Viridian
Jennifer M. Loh, MD
Consultant: Horizon, Novartis
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com